Elkfork Partners LLC purchased a new position in Walgreens Boots Alliance Inc (NASDAQ:WBA) during the fourth quarter, Holdings Channel reports. The fund purchased 134,484 shares of the pharmacy operator’s stock, valued at approximately $9,766,000.
Other institutional investors and hedge funds also recently modified their holdings of the company. Andra AP fonden boosted its position in shares of Walgreens Boots Alliance by 6.9% in the 3rd quarter. Andra AP fonden now owns 62,300 shares of the pharmacy operator’s stock worth $4,811,000 after purchasing an additional 4,000 shares in the last quarter. Chesley Taft & Associates LLC lifted its position in Walgreens Boots Alliance by 48.6% in the 4th quarter. Chesley Taft & Associates LLC now owns 261,369 shares of the pharmacy operator’s stock valued at $18,981,000 after acquiring an additional 85,423 shares in the last quarter. First Trust Advisors LP lifted its position in Walgreens Boots Alliance by 10.3% in the 4th quarter. First Trust Advisors LP now owns 748,421 shares of the pharmacy operator’s stock valued at $54,350,000 after acquiring an additional 69,650 shares in the last quarter. CI Investments Inc. bought a new position in Walgreens Boots Alliance in the 3rd quarter valued at approximately $27,555,000. Finally, Griffin Asset Management Inc. lifted its position in Walgreens Boots Alliance by 10.6% in the 3rd quarter. Griffin Asset Management Inc. now owns 95,032 shares of the pharmacy operator’s stock valued at $7,338,000 after acquiring an additional 9,090 shares in the last quarter. 60.93% of the stock is currently owned by hedge funds and other institutional investors.
Shares of WBA stock opened at $65.43 on Friday. The firm has a market cap of $65,651.63, a price-to-earnings ratio of 18.07, a price-to-earnings-growth ratio of 1.09 and a beta of 1.21. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.47 and a current ratio of 0.96. Walgreens Boots Alliance Inc has a 12 month low of $63.82 and a 12 month high of $87.79.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share for the quarter, beating analysts’ consensus estimates of $1.27 by $0.01. The business had revenue of $30.74 billion during the quarter, compared to analyst estimates of $30.39 billion. Walgreens Boots Alliance had a net margin of 3.19% and a return on equity of 19.15%. The company’s quarterly revenue was up 7.9% compared to the same quarter last year. During the same period in the previous year, the business earned $1.10 EPS. equities research analysts predict that Walgreens Boots Alliance Inc will post 5.79 earnings per share for the current year.
The business also recently announced a quarterly dividend, which was paid on Monday, March 12th. Shareholders of record on Thursday, February 15th were paid a dividend of $0.40 per share. The ex-dividend date was Wednesday, February 14th. This represents a $1.60 dividend on an annualized basis and a yield of 2.45%. Walgreens Boots Alliance’s dividend payout ratio is presently 44.20%.
WBA has been the topic of several analyst reports. Deutsche Bank initiated coverage on Walgreens Boots Alliance in a research report on Monday, December 4th. They issued a “hold” rating and a $78.00 price objective on the stock. Vetr raised Walgreens Boots Alliance from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, December 12th. Zacks Investment Research raised Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $82.00 price objective on the stock in a research report on Saturday, January 13th. Robert W. Baird reaffirmed a “buy” rating and issued a $82.00 price objective on shares of Walgreens Boots Alliance in a research report on Thursday, January 4th. Finally, BidaskClub cut Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a research report on Thursday. One equities research analyst has rated the stock with a sell rating, ten have assigned a hold rating, twelve have issued a buy rating and one has issued a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $84.45.
In related news, insider Stefano Pessina acquired 98,858 shares of Walgreens Boots Alliance stock in a transaction dated Monday, January 15th. The stock was purchased at an average cost of $76.07 per share, for a total transaction of $7,520,128.06. The purchase was disclosed in a filing with the SEC, which is available through this link. 14.80% of the stock is currently owned by insiders.
WARNING: “Elkfork Partners LLC Purchases Shares of 134,484 Walgreens Boots Alliance Inc (WBA)” was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this story on another domain, it was stolen and reposted in violation of US and international trademark & copyright legislation. The legal version of this story can be accessed at https://www.dispatchtribunal.com/2018/03/24/elkfork-partners-llc-purchases-shares-of-134484-walgreens-boots-alliance-inc-wba.html.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.